We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
Fmoc-N-Me-Phe-OH is a peptide inhibitor of Malaria Parasite.
CAT No: R1361
CAS No: 77128-73-5
Synonyms/Alias: Fmoc-N-Me-Phe-OH;77128-73-5;Fmoc-MePhe-OH;Fmoc-N-methyl-L-phenylalanine;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-phenylpropanoic acid;N-Fmoc-N-methyl-L-phenylalanine;Fmoc-N-Me-L-Phe-OH;(2S)-2-[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]-3-phenylpropanoic acid;MFCD00151938;N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-methyl-L-phenylalanine;Fmoc-L-MePhe-OH;N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-alpha-methyl-L-phenylalanine;(S)-2-[[[(9H-Fluoren-9-yl)methoxy]carbonyl](methyl)amino]-3-phenylpropanoic acid;Fmoc-Nalpha-methyl-L-phenylalanine;L-Phenylalanine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-methyl-;(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl](methyl)amino}-3-phenylpropanoic acid;SCHEMBL120595;GBROUWPNYVBLFO-QHCPKHFHSA-N;ZB0880;AKOS015837150;AKOS015908459;CS-W011702;HY-W010986;AC-24162;DA-63560;DS-13395;F1167;EN300-1692653;Fmoc-N-Me-Phe-OH, >=99.0% (sum of enantiomers, HPLC);N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N-methyl-L-phenylalanine;(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}(methyl)amino)-3-phenylpropanoic acid;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-phenylpropanoicacid;844-850-8;
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C25H23NO4 |
M.W/Mr. | 401.5 |
Sequence | One Letter Code:F Three Letter Code:Fmoc-N(Me)Phe-OH |
Application | Screening of peptide synthetic drugs |
Abbr | Fmoc-MePhe-OH |
InChI | InChI=1S/C25H23NO4/c1-26(23(24(27)28)15-17-9-3-2-4-10-17)25(29)30-16-22-20-13-7-5-11-18(20)19-12-6-8-14-21(19)22/h2-14,22-23H,15-16H2,1H3,(H,27,28)/t23-/m0/s1 |
InChI Key | GBROUWPNYVBLFO-QHCPKHFHSA-N |
Canonical SMILES | CN(C(CC1=CC=CC=C1)C(=O)O)C(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24 |
1. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com